Lara Cortes, APRN
Adult Health · Tarpon Springs, FLNPI 1790254639
Payments from drug & device makers
Across 182 payments — averaging $17.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$408
- Johnson & Johnson$314
- Novo Nordisk$270
- Pfizer$252
- Otsuka America Pharmaceutical, Inc.$197
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$176
- plus $2K from 30 others
What the payments were for
- Food & beverage$3,161100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 20 | $408 |
| Johnson & Johnson | 11 | $314 |
| Novo Nordisk | 20 | $270 |
| Pfizer | 15 | $252 |
| Otsuka America Pharmaceutical, Inc. | 11 | $197 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $176 |
| Amarin Pharma, Inc. | 14 | $173 |
| Lilly USA, LLC | 11 | $168 |
| Abbott | 7 | $126 |
| GSK | 4 | $82 |
| Merck | 4 | $79 |
| Clarus Therapeutics Inc. | 5 | $77 |
| Dexcom, Inc. | 5 | $77 |
| Biohaven Pharmaceuticals, Inc. | 4 | $67 |
| Astellas Pharma US Inc | 3 | $66 |
| AstraZeneca | 4 | $63 |
| Bayer | 3 | $58 |
| Novartis | 3 | $57 |
| Neurocrine Biosciences, Inc. | 3 | $48 |
| Paratek Pharmaceuticals, Inc. | 2 | $42 |
| Medtronic | 2 | $40 |
| E.r. Squibb & Sons, L.L.C. | 2 | $38 |
| Acerus Pharmaceuticals Corporation | 2 | $34 |
| Hikma Pharmaceuticals USA | 2 | $34 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
| Boston Scientific | 1 | $25 |
| Eisai Inc. | 1 | $24 |
| Eyevance Pharmaceuticals LLC | 1 | $22 |
| Boehringer Ingelheim | 1 | $19 |
| Biogen | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
| Electromed, Inc. | 2 | $15 |
| Avanir Pharmaceuticals, Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $8 |
How this compares
$3,172 in reported general payments places this provider in the 80th percentile of 2,237 adult health providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 55 | $758 |
| Levothyroxine Sodium | 40 | $583 |
| Metoprolol Succinate | 19 | $260 |
| Losartan Potassium | 24 | $260 |
| Atorvastatin Calcium | 32 | $244 |
| Lisinopril | 27 | $208 |
| Amlodipine Besylate | 32 | $180 |
| Gabapentin | 18 | $162 |
| Escitalopram Oxalate | 19 | $161 |
| Trazodone Hcl | 13 | $157 |
| Metformin Hcl | 12 | $101 |
| Metformin Hcl ErMetformin Hcl | 15 | $79 |
| Metoprolol Tartrate | 11 | $62 |
| Simvastatin | 15 | $56 |
Paid to pharmacies, not to this prescriber.
Other adult health in Tarpon Springs
- Patricia PagnottaMaitland$441K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
- Alejandro Dela CruzOrlando$44K
- Cynthia OteroMaitland$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.